BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
At the same time, the fintech has also seemingly achieved the critical operating scale and brand power to "price our services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback